Masimo PE Ratio 2010-2024 | MASI
Current and historical p/e ratio for Masimo (MASI) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Masimo PE ratio as of January 10, 2025 is 43.67.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Masimo PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-01-10 | 166.42 | 114.77 | |
| 2024-09-30 | 133.33 | $1.45 | 91.95 |
| 2024-06-30 | 125.94 | $1.47 | 85.67 |
| 2024-03-31 | 146.85 | $1.47 | 99.90 |
| 2023-12-31 | 117.21 | $1.51 | 77.62 |
| 2023-09-30 | 87.68 | $1.64 | 53.46 |
| 2023-06-30 | 164.55 | $2.14 | 76.89 |
| 2023-03-31 | 184.54 | $2.18 | 84.65 |
| 2022-12-31 | 147.95 | $2.60 | 56.90 |
| 2022-09-30 | 141.16 | $3.02 | 46.74 |
| 2022-06-30 | 130.67 | $3.20 | 40.83 |
| 2022-03-31 | 145.54 | $3.79 | 38.40 |
| 2021-12-31 | 292.78 | $4.19 | 69.88 |
| 2021-06-30 | 242.45 | $3.86 | 62.81 |
| 2021-03-31 | 229.66 | $3.94 | 58.29 |
| 2020-12-31 | 268.38 | $4.14 | 64.83 |
| 2020-09-30 | 236.06 | $3.85 | 61.31 |
| 2020-06-30 | 227.99 | $3.86 | 59.06 |
| 2020-03-31 | 177.12 | $3.69 | 48.00 |
| 2019-12-31 | 158.06 | $3.44 | 45.95 |
| 2019-09-30 | 148.79 | $3.35 | 44.41 |
| 2019-06-30 | 148.82 | $3.51 | 42.40 |
| 2019-03-31 | 138.28 | $3.54 | 39.06 |
| 2018-12-31 | 107.37 | $2.68 | 40.06 |
| 2018-09-30 | 124.54 | $2.55 | 48.84 |
| 2018-03-31 | 87.95 | $2.36 | 37.27 |
| 2017-12-31 | 84.80 | $2.36 | 35.93 |
| 2017-09-30 | 86.56 | $6.32 | 13.70 |
| 2017-06-30 | 91.18 | $6.14 | 14.85 |
| 2017-03-31 | 93.26 | $5.88 | 15.86 |
| 2016-12-31 | 67.40 | $5.59 | 12.06 |
| 2016-09-30 | 59.49 | $2.08 | 28.60 |
| 2016-06-30 | 52.52 | $1.92 | 27.35 |
| 2016-03-31 | 41.84 | $1.71 | 24.47 |
| 2015-12-31 | 41.51 | $1.56 | 26.61 |
| 2015-09-30 | 38.56 | $1.50 | 25.71 |
| 2015-06-30 | 38.74 | $1.41 | 27.48 |
| 2015-03-31 | 32.98 | $1.29 | 25.57 |
| 2014-12-31 | 26.34 | $1.30 | 20.26 |
| 2014-09-30 | 21.28 | $1.06 | 20.08 |
| 2014-06-30 | 23.60 | $1.06 | 22.26 |
| 2014-03-31 | 27.31 | $1.12 | 24.38 |
| 2013-12-31 | 29.23 | $1.01 | 28.94 |
| 2013-09-30 | 26.64 | $1.11 | 24.00 |
| 2013-06-30 | 21.20 | $1.08 | 19.63 |
| 2013-03-31 | 19.62 | $1.08 | 18.17 |
| 2012-12-31 | 21.01 | $1.59 | 13.21 |
| 2012-09-30 | 23.07 | $1.56 | 14.79 |
| 2012-06-30 | 21.35 | $1.56 | 13.69 |
| 2018-06-30 | 97.65 | $1.54 | 63.41 |
| 2011-12-31 | 17.83 | $1.04 | 17.14 |
| 2011-09-30 | 20.64 | $1.07 | 19.29 |
| 2011-06-30 | 28.32 | $1.10 | 25.74 |
| 2011-03-31 | 31.58 | $1.09 | 28.97 |
| 2010-12-31 | 27.74 | $1.04 | 26.67 |
| 2012-03-31 | 22.31 | $1.22 | 18.28 |
| 2010-09-30 | 25.46 | $1.18 | 21.58 |
| 2010-06-30 | 22.20 | $1.13 | 19.64 |
| 2010-03-31 | 24.75 | $1.11 | 22.30 |
| 2009-12-31 | 26.39 | $0.89 | 29.65 |
| 2009-09-30 | 22.73 | $1.66 | 13.69 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $9.025B | $2.048B |
| Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. The device also measures pulse rate. Apart from blood monitoring, the company has also ventured into non-invasive blood constituent, brain and breathe monitoring. The company's rainbow Pulse CO-Oximetry measures blood constituents that include total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and SET measurements of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVi). Rainbow Acoustic Monitoring measures respiration rate (RRa) non-invasively and on a continuous basis. SedLine monitors brain functioning of patients under anesthesia or sedation. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $199.883B | 24.39 |
| Intuitive Surgical (ISRG) | United States | $186.649B | 97.58 |
| Edwards Lifesciences (EW) | United States | $42.814B | 27.19 |
| Alcon (ALC) | Switzerland | $41.161B | 27.54 |
| IQVIA Holdings (IQV) | United States | $35.414B | 19.51 |
| IDEXX Laboratories (IDXX) | United States | $33.479B | 39.43 |
| DexCom (DXCM) | United States | $30.662B | 46.18 |
| Waters (WAT) | United States | $21.866B | 32.33 |
| STERIS (STE) | Ireland | $19.984B | 23.01 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.343B | 0.00 |
| Hologic (HOLX) | United States | $16.281B | 17.58 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.998B | 13.34 |
| Sysmex ADR (SSMXY) | Japan | $11.450B | 35.90 |
| Globus Medical (GMED) | United States | $11.143B | 28.22 |
| Penumbra (PEN) | United States | $9.211B | 90.22 |
| Teleflex (TFX) | United States | $8.316B | 13.26 |
| Glaukos (GKOS) | United States | $8.253B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.433B | 25.13 |
| PROCEPT BioRobotics (PRCT) | United States | $4.340B | 0.00 |
| Veracyte (VCYT) | United States | $3.134B | 94.05 |
| Inari Medical (NARI) | United States | $3.033B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.533B | 14.62 |
| Tandem Diabetes Care (TNDM) | United States | $2.354B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.318B | 17.61 |
| TransMedics (TMDX) | United States | $2.232B | 70.75 |
| Elekta AB (EKTAY) | Sweden | $2.095B | 18.83 |
| Integra LifeSciences Holdings (IART) | United States | $1.776B | 9.28 |
| RxSight (RXST) | United States | $1.393B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.285B | 0.00 |
| Artivion (AORT) | United States | $1.177B | 78.00 |
| Pulse Biosciences (PLSE) | United States | $1.094B | 0.00 |
| OPKO Health (OPK) | United States | $0.990B | 0.00 |
| Paragon 28 (FNA) | United States | $0.897B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.728B | 12.37 |
| AxoGen (AXGN) | United States | $0.722B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.717B | 16.90 |
| IRadimed (IRMD) | United States | $0.696B | 37.63 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.660B | 0.00 |
| SiBone (SIBN) | United States | $0.584B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.554B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.506B | 26.63 |
| Pacific Biosciences Of California (PACB) | United States | $0.493B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.490B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.429B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.411B | 22.23 |
| Delcath Systems (DCTH) | United States | $0.403B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.365B | 0.00 |
| NeuroPace (NPCE) | United States | $0.346B | 0.00 |
| CVRx (CVRX) | United States | $0.330B | 0.00 |
| Inogen (INGN) | United States | $0.219B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.217B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.199B | 0.00 |
| Accuray (ARAY) | United States | $0.196B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.182B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.178B | 0.00 |
| Nevro (NVRO) | United States | $0.139B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.121B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.116B | 12.46 |
| LENSAR (LNSR) | United States | $0.101B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.099B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.089B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.082B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.082B | 0.00 |
| 908 Devices (MASS) | United States | $0.076B | 0.00 |
| Hyperfine (HYPR) | United States | $0.071B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.070B | 0.00 |
| InspireMD (NSPR) | Israel | $0.069B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.061B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.054B | 0.00 |
| Spectral AI (MDAI) | United States | $0.051B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.047B | 0.00 |
| Neuronetics (STIM) | United States | $0.045B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.042B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.034B | 0.00 | |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.032B | 0.00 |
| Envoy Medical (COCH) | United States | $0.031B | 0.00 |
| DarioHealth (DRIO) | United States | $0.028B | 0.00 |
| NexGel (NXGL) | United States | $0.026B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.024B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.019B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.017B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.014B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.013B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.012B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.011B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.008B | 0.00 |
| PAVmed (PAVM) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |